Cargando…
Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies
SIMPLE SUMMARY: Prostate cancer is one of the leading causes of cancer-related deaths among men in the United States and Europe. While conventional treatment options either have high toxicity profiles or are limited by the tumor’s ability to develop resistance, immunotherapy is specific in targeting...
Autores principales: | Steinbach, Christina, Merchant, Almas, Zaharie, Alexandru-Teodor, Horak, Peter, Marhold, Maximilian, Krainer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688882/ https://www.ncbi.nlm.nih.gov/pubmed/36428811 http://dx.doi.org/10.3390/cancers14225719 |
Ejemplares similares
-
Circulating Endothelial Progenitor Cells in Castration Resistant Prostate Cancer: A Randomized, Controlled, Biomarker Study
por: Fuereder, Thorsten, et al.
Publicado: (2014) -
Biochemical control after adjuvant radiation therapy for prostate cancer: a unicentric, retrospective analysis
por: Zaharie, Alexandru-Teodor, et al.
Publicado: (2021) -
MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice
por: Marhold, Maximilian, et al.
Publicado: (2022) -
Molecular and cellular mechanisms of castration resistant prostate cancer
por: Huang, Yiqiao, et al.
Publicado: (2018) -
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
por: Awang, Zool Hilmi, et al.
Publicado: (2018)